Publications

Export 2587 results:
Sort by: Author [ Title  (Desc)] Type Year
A [B] C D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
B
Abbassy, A. H. F., R. Wesam, H. El-Azizy, and S. M. el-Mashed, "B-Flow, Power Doppler and Color Doppler Ultrasound in the Assessment of Peripheral Arterial Stenosis: Comparison with 64-MD-CT Angiography", Med. J. Cairo Univ, vol. 85, issue 2, pp. 801-804, 2017.
Abbassy, A. H. F., R. Wesam, H. El-Azizy, and S. M. el-Mashed, "B-Flow, Power Doppler and Color Doppler Ultrasound in the Assessment of Carotid Stenosis: Comparison with 64-MD-CT Angiography", Med. J. Cairo Univ, vol. 85, issue 2, pp. 805-809,, 2017.
Shater, H., M. Fawzy, A. Farid, A. El-Amir, S. Fouad, and N. Madbouly, "B-cell activating factor and a proliferation-inducing ligand in relation to intima-media thickness as biomarkers of premature atherosclerosis in systemic lupus erythematosus …", The American Journal of the Medical Sciences, vol. 2022, 2022.
Shater, H., M. Fawzy, A. Farid, A. El-Amir, S. Fouad, and N. Madbouly, "B-cell activating factor and a proliferation-inducing ligand in relation to intima-media thickness as biomarkers of premature atherosclerosis in systemic lupus erythematosus patients", The American Journal of the Medical Sciences, 2022.
Zayed, R. A., H. F. Sheba, M. A. A. K. Elazaem, Z. A. Elsaadany, L. O. Elmessery, J. A. Mahmoud, D. A. R. Rahman, and F. R. Abdou, "B- Cell Activating Factor Promoter Polymorphisms in Egyptian Patients with Systemic Lupus Erythematosus.", Annals of Clinical & Laboratory Science, vol. 43, issue 3, pp. 111-116, 2013. Abstract

Background: Systemic lupus erythematosus (SLE) is a heterogonous autoimmune disease involving
most immune cells. Studies have revealed a number of cytokine pathways that play important roles in
the disease process. Among these are B- cell activating factor (BAFF), which regulates B-cell maturation,
survival, and function. Objective: To study the association between BAFF promoter polymorphism and
systemic lupus erythematosus (SLE). Methods: Single nucleotide polymorphisms in the BAFF promoter
region; -2841 (T>C), -2701 (T>A), -871 (C>T) were investigated by PCR-RFLP genotyping in fifty Egyptian
SLE patients and thirty normal controls. Results: The frequency of mutant alleles of both -871C>T
and -2701 T>A was higher among SLE patients than controls (p-value <0.001 and 0.000 respectively).
There was a highly significant relationship between -871 C>T polymorphism and SLE (P<0.001), with the
sensitivity and the specificity of the test being 100 %, and 70%, respectively. Patients expressing the -2701
T>A allele were seven times more prone to SLE than those with the T/T wild genotype (sensitivity of the
test = 78%, specificity = 66.7%, odds ratio = 7.09, C.I at 95% = 2.29-22.64). Conclusion: Polymorphisms
in the regulatory region of the BAFF gene do contribute to the susceptibility to SLE in Egyptian patients,
which indicates BAFF as a potential therapeutic target.

Fattah, E. A., H. Y. A. Girgis, K. el Khashab, Z. A. Ashour, and G. M. Ezzat, "B type Natriuretic peptide as an index of symptoms and severity of chronic rheumatic Mitral regurgitation", Heart Views, vol. 17, issue 1, pp. 7-12, 2016.
SM, A. - H., and A. - L. HN, "B cell activating factor gene polymorphisms in patients with risk of idiopathic thrombocytopenic purpura.", Am J Med Sci., vol. 342, issue 1, pp. 9-14, 2011. CU-PDF.pdf
Elela, M. A., H. I. Gawdat, R. A. Hegazy, M. Fawzy, R. A. N. I. A. ABDEL HAY, D. Saadi, and O. Shaker, "B cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of Alopecia Areata.", Archives of Dermatologic Research, vol. 308, issue 2, pp. 115-121, 2016.
Elela, M. A., H. I. GAWDAT, R. A. HEGAZY, M. M. Fawzy, R. A. M. Hay, D. Saadi, and O. Shaker, "B cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of Alopecia Areata", Archives of Dermatological Research, vol. 308, issue 2: Springer Berlin Heidelberg, pp. 115-21. , 2016. Abstract

n/a

menna magdy, B, : cairo universty, 2013.